# Respa Pharmaceuticals Inc. – FDA Inspection, Oct 4, 2012

Source: https://www.keypedia.com/records/fda_inspections/respa-pharmaceuticals-inc/72083ff8-c4da-42a5-a9fc-9ac800c23b1c
Source feed: FDA_Inspections

> FDA inspection 801001 of Respa Pharmaceuticals Inc., October 04, 2012. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 211. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 801001
- Company Name: Respa Pharmaceuticals Inc.
- Inspection Date: 2012-10-04
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 3

## Related Documents

- [FDA Inspection 738390 - 2011-08-04](https://www.keypedia.com/records/fda_inspections/respa-pharmaceuticals-inc/d8a2e091-4c0e-4cc9-ac3f-10434a0e05ba)

Company: https://www.keypedia.com/companies/respa-pharmaceuticals-inc/52ed8716-7a4c-4652-b12c-9fe40d3ce929

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c